Literature DB >> 15079089

Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.

D Borden Lacy1, Darran J Wigelsworth, Heather M Scobie, John A T Young, R John Collier.   

Abstract

Anthrax toxin is released from Bacillus anthracis as three monomeric proteins, which assemble into toxic complexes at the surface of receptor-bearing host cells. One of the proteins, protective antigen (PA), binds to receptors and orchestrates the delivery of the other two (the lethal and edema factors) into the cytosol. PA has been shown to bind to two cellular receptors: anthrax toxin receptor/tumor endothelial marker 8 and capillary morphogenesis protein 2 (CMG2). Both are type 1 membrane proteins that include an approximately 200-aa extracellular von Willebrand factor A (VWA) domain with a metal ion-dependent adhesion site (MIDAS) motif. The anthrax toxin receptor/tumor endothelial marker 8 and CMG2 VWA domains share approximately 60% amino acid identity and bind PA directly in a metal-dependent manner. Here, we report the crystal structure of the CMG2 VWA domain, with and without its intramolecular disulfide bond, to 1.5 and 1.8 A, respectively. Both structures contain a carboxylate ligand-mimetic bound at the MIDAS and appear as open conformations when compared with the VWA domains from alpha-integrins. The CMG2 structures provide a template to begin probing the high-affinity CMG2-PA interaction (200 pM) and may facilitate understanding of toxin assembly/internalization and the development of new anthrax treatments. The structural data also allow molecular interpretation of known CMG2 VWA domain mutations linked to the genetic disorders, juvenile hyaline fibromatosis, and infantile systemic hyalinosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15079089      PMCID: PMC404051          DOI: 10.1073/pnas.0401506101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

2.  The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.

Authors:  Jeremy Mogridge; Kristina Cunningham; D Borden Lacy; Michael Mourez; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

3.  Cell surface tumor endothelial markers are conserved in mice and humans.

Authors:  E B Carson-Walter; D N Watkins; A Nanda; B Vogelstein; K W Kinzler; B St Croix
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

4.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

5.  Binding of anthrax toxin to its receptor is similar to alpha integrin-ligand interactions.

Authors:  Kenneth A Bradley; Jeremy Mogridge; G Jonah; A Rainey; Sarah Batty; John A T Young
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

6.  Anthrax protective antigen forms oligomers during intoxication of mammalian cells.

Authors:  J C Milne; D Furlong; P C Hanna; J S Wall; R J Collier
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

7.  Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18.

Authors:  P J Muchowski; L Zhang; E R Chang; H R Soule; E F Plow; M Moyle
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

8.  Structural and functional analysis of integrin alpha2I domain interaction with echovirus 1.

Authors:  Li Xing; Mikko Huhtala; Vilja Pietiäinen; Jarmo Käpylä; Kirsi Vuorinen; Varpu Marjomäki; Jyrki Heino; Mark S Johnson; Timo Hyypiä; R Holland Cheng
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

9.  Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.

Authors:  A M Friedlander
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

10.  Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures.

Authors:  R Li; P Rieu; D L Griffith; D Scott; M A Arnaout
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more
  55 in total

1.  Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.

Authors:  D Borden Lacy; Darran J Wigelsworth; Roman A Melnyk; Stephen C Harrison; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 2.  Cell adhesion molecule control of planar spindle orientation.

Authors:  Hüseyin Tuncay; Klaus Ebnet
Journal:  Cell Mol Life Sci       Date:  2015-12-23       Impact factor: 9.261

3.  Domain flexibility modulates the heterogeneous assembly mechanism of anthrax toxin protective antigen.

Authors:  Geoffrey K Feld; Alexander F Kintzer; Iok I Tang; Katie L Thoren; Bryan A Krantz
Journal:  J Mol Biol       Date:  2011-10-31       Impact factor: 5.469

4.  Receptor-specific requirements for anthrax toxin delivery into cells.

Authors:  G Jonah A Rainey; Darran J Wigelsworth; Patricia L Ryan; Heather M Scobie; R John Collier; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

5.  Polyvalent inhibitors of anthrax toxin that target host receptors.

Authors:  Saleem Basha; Prakash Rai; Vincent Poon; Arundhati Saraph; Kunal Gujraty; Mandy Y Go; Skanda Sadacharan; Mia Frost; Jeremy Mogridge; Ravi S Kane
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 6.  Complement and the multifaceted functions of VWA and integrin I domains.

Authors:  Timothy A Springer
Journal:  Structure       Date:  2006-11       Impact factor: 5.006

7.  Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.

Authors:  Kuang-Hua Chen; Shihui Liu; Laurie A Bankston; Robert C Liddington; Stephen H Leppla
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

8.  Onset of anthrax toxin pore formation.

Authors:  Mu Gao; Klaus Schulten
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

9.  The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.

Authors:  Mandy Y Go; Edith M C Chow; Jeremy Mogridge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

10.  Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease.

Authors:  Kathryn J Pflughoeft; Michelle C Swick; David A Engler; Hye-Jeong Yeo; Theresa M Koehler
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.